Core Viewpoint - The company, Hongli Medical Management, anticipates a net loss attributable to shareholders of no more than RMB 2 million for the six months ending June 30, 2025, a significant decline from a net profit of approximately RMB 20 million for the same period in 2024 [1] Group 1: Financial Performance - The expected shift from profit to loss is primarily attributed to a decrease in demand for inpatient medical services, leading to reduced revenue [1] - The actual settlement rates from the public medical insurance plan for the fiscal year 2024, completed in May 2025, were lower than the estimated settlement rates used in the consolidated financial statements for the year ending December 31, 2024, resulting in decreased inpatient service revenue [1] - The company further adjusted the estimated settlement rates for inpatient service revenue covered by the plan for the first half of 2025 downward due to the aforementioned discrepancies [1]
宏力医疗管理(09906.HK)盈警：预期中期公司拥有人应占净亏不超200万元